Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025
Change company Symbol lookup
Select an option...
PXSAW Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025
TAP Molson Coors Beverage Co
CLS Celestica Inc
TWOU 2U Inc
CGTX Cognition Therapeutics Inc
BHAT Blue Hat Interactive Entertainment Technology
DBTX Decibel Therapeutics Inc
CLSK CleanSpark Inc
AER AerCap Holdings NV
AOD Aberdeen Total Dynamic Dividend Fund
Go

Industrials : Marine | Small Cap Value
Based in Greece
Company profile

Pyxis Tankers Inc. is a maritime transportation holding company. The Company is focused on the product tanker sector. It owns a fleet of six double hull product tankers: Pyxis Epsilon with carrying capacity of approximately 50,295 deadweight tonnage (dwt); Pyxis Theta with carrying capacity of approximately 51,795 dwt, Pyxis Malou with carrying capacity of over 50,667 dwt; Pyxis Delta with carrying capacity of approximately 46,616 dwt; Northsea Beta with carrying capacity of over 8,647 dwt, and Northsea Alpha with carrying capacity of approximately 8,615 dwt. Four of the Company's vessels in the fleet are medium-range (MR), product tankers, three have eco-efficient or eco-modified designs, and two of them are short-range tanker sister ships. Its fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel and fuel oil, as well as other liquid bulk items, such as vegetable oils and organic chemicals.

Closing Price
$0.3524
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
6,970
0

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IBM, MYPS and AUPH

6:48 pm ET May 17, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 17, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

International Business Machines Corporation (NYSE:IBM)

Class Period: April 4, 2017 - October 20, 2021

Lead Plaintiff Deadline: June 6, 2022



Throughout the class period, International Business Machines Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

Learn about your recoverable losses in IBM: https://www.kleinstocklaw.com/pslra-1/international-business-machines-corporation-loss-submission-form?id=27383&from=1

Playstudios, Inc. (NASDAQ:MYPS)

This lawsuit is on behalf of a class consisting of all persons and entities other than defendants who: (a) purchased, or otherwise acquired securities of Playstudios between June 22, 2021 and March 1, 2022, both dates inclusive, including, but not limited to, those who purchased or acquired Playstudios securities pursuant to the offering of the private investment in public equity; (b) held common stock of Acies as of May 25, 2021, and were eligible to vote at Acies' June 16, 2021 special meeting who exchanged their shares of Acies stock for shares of Playstudios stock pursuant to the merger of Acies and Old Playstudios; and/or (c) purchased or otherwise acquired Playstudios common stock pursuant to or traceable to Acies' documents issued in connection with the June 2021 merger.

Lead Plaintiff Deadline: June 6, 2022



Playstudios, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Playstudios was having significant problems with its flagship game, Kingdom Boss; (ii) Playstudios would not be releasing Kingdom Boss as expected; and (iii) Playstudios had not revised its financial projections to account for the problems it had encountered with Kingdom Boss. As a result of defendants' wrongful conduct, Class members paid artificially inflated prices for their Playstudios securities and suffered substantial losses and damages.

Learn about your recoverable losses in MYPS: https://www.kleinstocklaw.com/pslra-1/playstudios-inc-loss-submission-form?id=27383&from=1

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)

Class Period: May 7, 2021 - February 25, 2022

Lead Plaintiff Deadline: June 14, 2022



During the class period, Aurinia Pharmaceuticals Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia's 2022 sales outlook for the Company's only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AUPH: https://www.kleinstocklaw.com/pslra-1/aurinia-pharmaceuticals-inc-loss-submission-form?id=27383&from=1

The Klein Law Firm, Tuesday, May 17, 2022, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE: The Klein Law Firm





View source version on accesswire.com:

https://www.accesswire.com/701821/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-IBM-MYPS-and-AUPH



comtex tracking

COMTEX_407353407/2457/2022-05-17T18:48:57

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.